Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2013; 19(45): 8335-8341
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8335
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8335
Marker | Sensitivity | 95%CI | Specificity | 95%CI |
Procalcitonin (ng/mL) | ||||
> 0.0250 | 100% | 59.04-100.0 | 27.27% | 6.022-60.97 |
> 0.0400 | 100% | 59.04-100.0 | 72.73% | 39.03-93.98 |
> 0.0550 | 100% | 59.04-100.0 | 100% | 71.51-100.0 |
> 0.0650 | 71.43% | 29.04-96.33 | 100% | 71.51-100.0 |
> 0.0850 | 57.14% | 18.41-90.10 | 100% | 71.51-100.0 |
> 0.1050 | 42.86% | 9.899-81.59 | 100% | 71.51-100.0 |
> 0.1150 | 28.57% | 3.669-70.96 | 100% | 71.51-100.0 |
> 0.1350 | 14.29% | 0.3610-57.87 | 100% | 71.51-100.0 |
C-reactive protein (mg/dL) | ||||
> 0.2500 | 100% | 59.04-100.0 | 27.27% | 6.022-60.97 |
> 0.5000 | 85.71% | 42.13-99.64 | 36.36% | 10.93-69.21 |
> 0.7000 | 85.71% | 42.13-99.64 | 45.45% | 16.75-76.62 |
> 0.9000 | 85.71% | 42.13-99.64 | 63.64% | 30.79-89.07 |
> 1.400 | 85.71% | 42.13-99.64 | 72.73% | 39.03-93.98 |
> 2.600 | 85.71% | 42.13-99.64 | 81.82% | 48.22-97.72 |
> 3.600 | 85.71% | 42.13-99.64 | 90.91% | 58.72-99.77 |
> 4.050 | 71.43% | 29.04-96.33 | 90.91% | 58.72-99.77 |
> 4.700 | 71.43% | 29.04-96.33 | 100% | 71.51-100.0 |
> 7.100 | 57.14% | 18.41-90.10 | 100% | 71.51-100.0 |
> 9.850 | 42.86% | 9.899-81.59 | 100% | 71.51-100.0 |
> 10.75 | 28.57% | 3.669-70.96 | 100% | 71.51-100.0 |
> 11.35 | 14.29% | 0.3610-57.87 | 100% | 71.51-100.0 |
> 11.35 | 14.29% | 0.3610-57.87 | 100% | 76.84-100.0 |
- Citation: Koido S, Ohkusa T, Takakura K, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Kajihara M, Uchiyama K, Arakawa H, Tajiri H. Clinical significance of serum procalcitonin in patients with ulcerative colitis. World J Gastroenterol 2013; 19(45): 8335-8341
- URL: https://www.wjgnet.com/1007-9327/full/v19/i45/8335.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i45.8335